Best Stocks Under $3 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $3.00 (3 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Senseonics NYSE:SENS$0.46 +0.00 (+1.03%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$0.46 +0.00 (+0.43%) As of 09/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. More about SenseonicsMarket Capitalization$370.92 millionP/E Ratio-3.54Consensus RatingBuyConsensus Price Target$1.54 (+234.2% Upside)Volume5.35 million sharesAverage Volume7.97 million shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. TuHURA Biosciences NASDAQ:HURA$2.50 -0.09 (-3.47%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$2.59 +0.09 (+3.56%) As of 09/12/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA BiosciencesMarket Capitalization$129.62 millionConsensus RatingBuyConsensus Price Target$12.67 (+406.7% Upside)Volume138,253 sharesAverage Volume271,901 sharesToday's Range$2.50▼$2.643. Climb Bio NASDAQ:CLYM$2.25 -0.15 (-6.25%) As of 09/12/2025 04:00 PM EasternClimb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. More about Climb BioMarket Capitalization$162.63 millionP/E Ratio-3.21Consensus RatingBuyConsensus Price Target$9.00 (+300.0% Upside)Volume404,709 sharesAverage Volume615,476 shares4. Western Copper & Gold NYSE:WRN$1.67 +0.07 (+4.38%) As of 09/12/2025 04:00 PM EasternWestern Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & GoldMarket Capitalization$322.64 millionP/E Ratio-83.50Consensus RatingBuyConsensus Price Target$4.00 (+139.5% Upside)Volume493,235 sharesAverage Volume387,254 shares5. Stardust Power NASDAQ:SDST$2.80 -0.05 (-1.75%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$2.76 -0.03 (-1.25%) As of 09/12/2025 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.Market Capitalization$24.11 millionP/E Ratio-0.50Consensus RatingBuyConsensus Price Target$51.13 (+1,725.9% Upside)Volume128,880 sharesAverage Volume116,720 shares6. Plus Therapeutics NASDAQ:PSTV$0.45 -0.02 (-4.81%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$0.45 0.00 (-0.07%) As of 09/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Plus Therapeutics, Inc, a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. More about Plus TherapeuticsMarket Capitalization$46.65 millionP/E Ratio-0.20Consensus RatingBuyConsensus Price Target$7.88 (+1,660.6% Upside)Volume5.04 million sharesAverage Volume6.27 million shares7. ImmunityBio NASDAQ:IBRX$2.60 +0.01 (+0.39%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$2.60 0.00 (-0.19%) As of 09/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ImmunityBio, Inc, a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. More about ImmunityBioMarket Capitalization$2.45 billionP/E Ratio-5.42Consensus RatingBuyConsensus Price Target$10.75 (+313.5% Upside)Volume7.70 million sharesAverage Volume8.67 million shares8. Immunic NASDAQ:IMUX$0.79 -0.06 (-6.77%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$0.80 +0.00 (+0.21%) As of 09/12/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about ImmunicMarket Capitalization$84.05 millionP/E Ratio-0.85Consensus RatingBuyConsensus Price Target$8.33 (+949.1% Upside)Volume2.25 million sharesAverage Volume1.23 million shares9. Mereo BioPharma Group NASDAQ:MREO$1.85 +0.03 (+1.65%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.84 -0.01 (-0.54%) As of 09/12/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma GroupMarket Capitalization$289.38 millionP/E Ratio-26.43Consensus RatingBuyConsensus Price Target$7.40 (+300.0% Upside)Volume766,362 sharesAverage Volume897,251 shares10. zSpace NASDAQ:ZSPC$1.55 -0.15 (-8.82%) As of 09/12/2025 04:00 PM EasternzSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpaceMarket Capitalization$40.86 millionConsensus RatingBuyConsensus Price Target$10.00 (+545.2% Upside)Volume129,076 sharesAverage Volume97,479 sharesToday's Range$1.53▼$1.7911. Ur Energy NYSEAMERICAN:URG$1.46 -0.02 (-1.35%) Closing price 09/12/2025 04:10 PM EasternExtended Trading$1.46 +0.01 (+0.34%) As of 09/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur EnergyMarket Capitalization$539.95 millionP/E Ratio-8.59Consensus RatingBuyConsensus Price Target$2.48 (+69.5% Upside)Volume4.92 million sharesAverage Volume5.95 million shares12. Quince Therapeutics NASDAQ:QNCX$1.60 +0.02 (+1.27%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.62 +0.02 (+1.56%) As of 09/12/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince TherapeuticsMarket Capitalization$84.87 millionP/E Ratio-1.47Consensus RatingBuyConsensus Price Target$8.14 (+408.9% Upside)Volume132,719 sharesAverage Volume118,294 shares13. Ovid Therapeutics NASDAQ:OVID$1.26 +0.01 (+0.80%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.27 +0.01 (+1.19%) As of 09/12/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid TherapeuticsMarket Capitalization$88.89 millionP/E Ratio-2.38Consensus RatingBuyConsensus Price Target$3.10 (+146.0% Upside)Volume614,186 sharesAverage Volume1.62 million shares14. Biomea Fusion NASDAQ:BMEA$1.93 -0.05 (-2.53%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.92 -0.01 (-0.78%) As of 09/12/2025 05:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Biomea Fusion, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. More about Biomea FusionMarket Capitalization$117.83 millionP/E Ratio-0.64Consensus RatingBuyConsensus Price Target$14.80 (+666.8% Upside)Volume527,598 sharesAverage Volume533,113 shares15. Context Therapeutics NASDAQ:CNTX$0.84 0.00 (-0.12%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$0.85 +0.02 (+1.80%) As of 09/12/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context TherapeuticsMarket Capitalization$74.99 millionP/E Ratio-2.32Consensus RatingBuyConsensus Price Target$5.25 (+528.7% Upside)Volume42,938 sharesAverage Volume149,030 shares16. Reviva Pharmaceuticals NASDAQ:RVPH$0.44 0.00 (-0.18%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$0.44 0.00 (-0.07%) As of 09/12/2025 06:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva PharmaceuticalsMarket Capitalization$30.13 millionP/E Ratio-0.68Consensus RatingBuyConsensus Price Target$5.20 (+1,075.7% Upside)Volume785,993 sharesAverage Volume1.99 million shares17. OnKure Therapeutics NASDAQ:OKUR$2.45 +0.01 (+0.41%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$2.38 -0.07 (-3.02%) As of 09/12/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure TherapeuticsMarket Capitalization$33.01 millionP/E Ratio-0.51Consensus RatingBuyConsensus Price Target$32.33 (+1,219.7% Upside)Volume64,494 sharesAverage Volume66,702 shares18. Denison Mine NYSEAMERICAN:DNN$2.37 -0.06 (-2.47%) Closing price 09/12/2025 04:10 PM EasternExtended Trading$2.38 +0.01 (+0.63%) As of 09/12/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison MineMarket Capitalization$2.18 billionP/E Ratio-39.50Consensus RatingBuyConsensus Price Target$3.00 (+26.6% Upside)Volume59.09 million sharesAverage Volume53.48 million shares19. ProQR Therapeutics NASDAQ:PRQR$2.19 0.00 (0.00%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$2.18 0.00 (-0.23%) As of 09/12/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ProQR Therapeutics N.V., a biotechnology company, focuses on the discovery and development of novel therapeutic medicines. More about ProQR TherapeuticsMarket Capitalization$230.42 millionP/E Ratio-4.76Consensus RatingBuyConsensus Price Target$8.00 (+265.3% Upside)Volume472,345 sharesAverage Volume346,714 shares20. Aclaris Therapeutics NASDAQ:ACRS$1.95 -0.02 (-1.02%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.96 +0.01 (+0.26%) As of 09/12/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris TherapeuticsMarket Capitalization$213.41 millionP/E Ratio-1.42Consensus RatingBuyConsensus Price Target$8.71 (+346.9% Upside)Volume2.24 million sharesAverage Volume779,402 shares21. Orchestra BioMed NASDAQ:OBIO$2.57 -0.05 (-1.91%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$2.58 +0.01 (+0.19%) As of 09/12/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Orchestra BioMed Holdings, Inc operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. More about Orchestra BioMedMarket Capitalization$101.25 millionP/E Ratio-1.40Consensus RatingBuyConsensus Price Target$13.50 (+425.3% Upside)Volume119,272 sharesAverage Volume257,508 shares22. IceCure Medical NASDAQ:ICCM$0.99 -0.01 (-0.76%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$0.99 +0.01 (+0.66%) As of 09/12/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. More about IceCure MedicalMarket Capitalization$68.22 millionP/E Ratio-6.16Consensus RatingBuyConsensus Price Target$2.39 (+142.0% Upside)Volume584,429 sharesAverage Volume1.89 million shares23. Cabaletta Bio NASDAQ:CABA$1.84 +0.03 (+1.66%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.84 0.00 (0.00%) As of 09/12/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cabaletta Bio, Inc, a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. More about Cabaletta BioMarket Capitalization$165.55 millionP/E Ratio-0.68Consensus RatingBuyConsensus Price Target$14.50 (+688.0% Upside)Volume1.58 million sharesAverage Volume1.19 million shares24. Autolus Therapeutics NASDAQ:AUTL$1.38 -0.05 (-3.50%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.38 0.00 (0.00%) As of 09/12/2025 07:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. More about Autolus TherapeuticsMarket Capitalization$380.58 millionP/E Ratio-1.64Consensus RatingBuyConsensus Price Target$9.12 (+560.9% Upside)Volume5.53 million sharesAverage Volume4.36 million shares25. Akebia Therapeutics NASDAQ:AKBA$2.95 -0.04 (-1.34%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$2.95 0.00 (-0.14%) As of 09/12/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Akebia Therapeutics, Inc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. More about Akebia TherapeuticsMarket Capitalization$792.78 millionP/E Ratio-17.35Consensus RatingBuyConsensus Price Target$6.75 (+128.8% Upside)Volume2.25 million sharesAverage Volume3.81 million shares More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Not Just NVDA: 3 Semiconductor Stocks Struggling This Quarter Broadcom Gets Big Upgrades: How High Analysts See Shares Going Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
